BSEM 8-K 2026-09-18

BioStem Technologies, Inc. (BSEM) 8-K dated 2026-09-18 — accession 0001193125-26-395556.

BioStem Technologies, Inc. (BSEM) is a biotechnology company listed on US.

BioStem Technologies, Inc. filed a 8-K on 2026-09-18. Accession 0001193125-26-395556.

This 8-K covers: Material agreement (Item 1.01), Unregistered share sale (Item 3.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BSEM revenue for 2026-06-30 was $7.9M. Net income was -$9.0M. Revenue was down 27.9% from 2025-06-30 to 2026-06-30. BSEM currently screens at market cap $211.2M.

Not investment advice. The BSEM SEC hub lists recent forms. The stock page is the research view.